• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Dyax Corp. (DYAX)

    -NasdaqGM
    27.97 Down 0.46(1.62%) Apr 17, 4:00PM EDT
    |After Hours : 28.00 Up 0.03 (0.11%) Apr 17, 4:44PM EDT
    Add to Portfolio
    Prev Close:28.43
    Open:28.20
    Bid:27.97 x 100
    Ask:29.33 x 1000
    1y Target Est:29.75
    Beta:0.49
    Next Earnings Date:29-Apr-15DYAX Earnings announcement
    Day's Range:27.58 - 28.54
    52wk Range:6.05 - 30.55
    Volume:1,791,560
    Avg Vol (3m):1,824,720
    Market Cap:3.83B
    P/E (ttm):N/A
    EPS (ttm):-0.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    DYAXDown 1.62%3.83B
    SHPGUp 0.10%47.81B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):47.59
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.18
    Quarterly EPS Est (Mar-15) :-0.05
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):-8.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback